The company will raise Rs 4,500 crore through QIP, here is the complete information so far

News Topical, Digital Desk : There is a big news about the global biopharma company Biocon Limited. The company is soon preparing to raise Rs 4,500 crore through Qualified Institutional Placement (QIP). Moneycontrol has given this information in a report quoting three sources. No official information has been revealed yet about the fund raising by Biocon Limited.

On 23 April, the board of Biocon Limited approved raising 4,500 crores through QIP, rights issue or other means. On Monday, 16 June, the stock of Biocon Limited was seen trading almost flat at Rs 355 per share.

What information was received from sources? Moneycontrol has quoted sources in a report that the company was planning to raise funds for a long time, which can now start soon. Apart from this, quoting two other sources, it has been said that Kotak Mahindra Capital, Goldman Sachs and BoFA Securities can play the role of advisors in this process. Preparations to reduce debt? In this report, on 14 May, Executive Chairperson, Kiran Mazumdar Shaw has been quoted as saying that the company is planning to raise funds in 3-4 months. He cited the strong growth of the company behind this. He said that at such a time, if the debt is reduced and converted into promoter equity, then the health of the balance sheet will improve further. Let us tell you that Biocon has a net debt of $ 1.2 billion. The March quarter results have been strong Let us tell you that the fourth quarter of the financial year 2025 has been good for the company. During January-March, Biocon's net profit increased by 154% from Rs 135.5 crore to Rs 344.5 crore on an annual basis. During this period, the income also stood at Rs 4,417 crore on an annual basis. On the other hand, operating profit i.e. EBITDA has increased by 17.7% to Rs 1,078.2 crore.

Read More: The company will raise Rs 4,500 crore through QIP, here is the complete information so far